Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.265 USD | -0.27% | -3.13% | -17.44% |
05-13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
05-13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.44% | 452M | |
+34.05% | 693B | |
+29.39% | 584B | |
-2.85% | 372B | |
+20.58% | 332B | |
+6.67% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.00% | 168B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Earnings Flash (TBPH) THERAVANCE BIOPHARMA Posts Q1 Revenue $10.4M